Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: testing (1000), conducting tests (149)

Topotecan (1,8,15)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 8, 15) Regimen Ovary – Topotecan (1, 8, 15) Indication Second-line or subsequent treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan1815.pdf

Topotecan (1,8)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 8) Regimen Ovary – Topotecan (1, 8) Indication Second-line or subsequent treatment of platinum
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan18.pdf

Topotecan (1,2,3,4,5)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 2, 3, 4, 5) Regimen Ovary – Topotecan (1, 2, 3, 4, 5) Indication Second
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan12345.pdf

Etoposide PO

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER ETOPOSIDE ORAL Regimen Ovary-Etoposide Oral Indication Second line or subsequent treatment of recurrent platinum resistant ovarian
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/EtoposidePO.pdf

Panitumumab (21 day) Ver 1.1

Description: Chemotherapy Protocol COLORECTAL CANCER PANITUMUMAB (21 day) This regimen may require funding and is an unlicensed dose Regimen Colorectal Cancer – Panitumumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Panitumumab21dayVer11.pdf

ColorectalTrifluridineTipiricilVer1

Description: Chemotherapy Protocol Regimen COLORECTAL CANCER TRIFLURIDINE-TIPIRACIL  Colorectal Cancer – Trifluridine-Tipiracil Indication  Trifluridine-tipiracil is recommended as a third or subsequent
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/ColorectalTrifluridineTipiricilVer1.pdf

Map of Services 2021

Description: UHS Research & Development – Grants & Contracts Map of Services Points of contact in R&D: Olivia Chalwin, Senior Contracts Manager Olivia.Chalwin
Url: /Media/Southampton-Clinical-Research/Grants/Download/Map-of-Services-2021.pdf

Map of Services 2020 - October

Description: UHS Research & Development – Grants & Contracts Map of Services Points of contact in R&D: Olivia Chalwin, Senior Contracts Manager Olivia.Chalwin
Url: /Media/Southampton-Clinical-Research/Grants/Download/Map-of-Services-2020-October.pdf

Communicating risk: words or numbers?

Description: Is it better to communicate risks to patients with words or statistics?
Url: /HealthProfessionals/Clinical-law-updates/Communicating-risk-words-or-numbers.aspx

Map of Services 2019

Description: UHS Research & Development - Grants Map of Services Points of contact in R&D: Bethan Bennett-Lloyd, Grants Manager Tel: 023 8120
Url: /Media/Southampton-Clinical-Research/Grants/Download/Map-of-Services-2019.pdf

311 to 320 of 517

Previous … 30 31 32 33 34 … Next